Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein S-glutathionylation is a reversible post-translational modification involving the covalent attachment of glutathione (GSH) to cysteine residues in proteins. This modification regulates protein structure, activity, and interactions, playing a critical role in redox signaling and protection against irreversible cysteine oxidation. Dysregulation is implicated in various diseases including cancer, cardiovascular dysfunction, and neurodegeneration.
Thiol-disulfide exchange; enzymatic catalysis altering protein function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein S-glutathionylation (PSSG).